Svoronos Dawn Insider Trades

Insider Trading History

Track insider trading activity for Svoronos Dawn. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $707k 10,507 shares
Last Trade
Jun 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$647k 12,100 shares
$53.46
$67.30
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $0 0 shares
Last Trade
Jun 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$141k 2,645 shares
$53.41
$67.30
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $1.86M 27,645 shares
Last Trade
Jun 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$141k 2,645 shares
$53.41
$67.30
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $1.77M 26,229 shares
Last Trade
Jun 01, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$75.6k 1,416 shares
$53.41
$67.30
Adverum Biotechnologies
Adverum Biotechnologies ADVM
Director
Holding Value $0 0 shares
Last Trade
Dec 09, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$21.8k 5,000 shares
$4.36
$4.36
Adverum Biotechnologies
Adverum Biotechnologies ADVM
Director
Holding Value $0 0 shares
Last Trade
Dec 09, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$163k 37,470 shares
$4.36
$4.36
Adverum Biotechnologies
Adverum Biotechnologies ADVM
Director
Holding Value $45.6k 10,450 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.2k 10,450 shares
$2.32
$4.36
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $1.14M 17,012 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$523k 17,012 shares
$30.73
$67.30
Acelyrin
Acelyrin SLRN
Director
Holding Value $0 0 shares
Last Trade
May 21, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$615k 270,851 shares
$2.27
$2.27
Adverum Biotechnologies
Adverum Biotechnologies ADVM
Director
Holding Value $45.9k 10,520 shares
Last Trade
Jun 17, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$77k 10,520 shares
$7.32
$4.36
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $1.05M 15,542 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$593k 15,542 shares
$38.16
$67.30
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $1.68M 25,000 shares
Last Trade
Aug 24, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$968k 25,000 shares
$38.70
$67.30
Adverum Biotechnologies
Adverum Biotechnologies ADVM
Director
Holding Value $174k 40,000 shares
Last Trade
Jun 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$62.4k 40,000 shares
$1.56
$4.36
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $1.24M 18,475 shares
Last Trade
Jun 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$720k 18,475 shares
$38.96
$67.30
Acelyrin
Acelyrin SLRN
Director
Holding Value $353k 155,450 shares
Last Trade
May 09, 2023 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$4.41M 178,693 shares
$24.69
$2.27
Acelyrin
Acelyrin SLRN
Director
Holding Value $0 0 shares
Last Trade
May 09, 2023 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$4.41M 178,693 shares
$24.69
$2.27
Acelyrin
Acelyrin SLRN
Director
Holding Value $34.1k 15,000 shares
Last Trade
May 09, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$370k 15,000 shares
$24.69
$2.27
Acelyrin
Acelyrin SLRN
Director
Holding Value $52.8k 23,243 shares
Last Trade
May 04, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$2.27
Global Blood Therapeutics
Global Blood Therapeutics GBT
Director
Holding Value $0 0 shares
Last Trade
Oct 05, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$384k 5,600 shares
$68.49
$68.49
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Director
Holding Value $1.21M 18,000 shares
Last Trade
Jun 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.08M 36,000 shares
$30.11
$67.30

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up